Drug Patent Expirations in May 2014

Drug Patent Expirations for May 2014

Tradename Applicant Generic Name Patent Number Patent Expiration
RYZOLT Purdue Pharma tramadol hydrochloride 6,254,887 May 10, 2014
RYZOLT Purdue Pharma tramadol hydrochloride 5,591,452 May 10, 2014
TRITEC Glaxosmithkline ranitidine bismuth citrate 5,629,297 May 13, 2014
THALOMID Celgene thalidomide 5,629,327 May 13, 2014
IMAGENT Imcor Pharms Co dimyristoyl lecithin; perflexane 5,626,833 May 16, 2014
RESTASIS Allergan cyclosporine 5,474,979 May 17, 2014
CHILDREN'S ALLEGRA ALLERGY Sanofi Aventis Us fexofenadine hydrochloride 7,138,524 May 18, 2014
CHILDREN'S ALLEGRA HIVES Sanofi Aventis Us fexofenadine hydrochloride 7,138,524 May 18, 2014
RISPERDAL CONSTA Janssen Pharms risperidone 6,368,632*PED May 19, 2014
NATRECOR Scios Llc nesiritide recombinant 5,114,923 May 19, 2014
RISPERDAL CONSTA Janssen Pharms risperidone 6,110,921*PED May 19, 2014
RISPERDAL CONSTA Janssen Pharms risperidone 7,547,452*PED May 19, 2014
KALETRA Abbvie lopinavir; ritonavir 5,886,036*PED May 19, 2014
RISPERDAL CONSTA Janssen Pharms risperidone 5,965,168*PED May 19, 2014
LUPRON DEPOT Abbvie Endocrine Inc leuprolide acetate 5,631,020 May 20, 2014
LUPRON DEPOT Abbvie Endocrine Inc leuprolide acetate 5,631,021 May 20, 2014
ZINGO Powder Pharms lidocaine hydrochloride 5,630,796 May 20, 2014
LUPRON DEPOT-PED Abbvie Endocrine Inc leuprolide acetate 5,631,020 May 20, 2014
INOMAX Ino nitric oxide 5,558,083*PED May 22, 2014
TAXOTERE Sanofi Aventis Us docetaxel 5,438,072*PED May 22, 2014
COPAXONE Teva Pharms Usa glatiramer acetate 6,342,476 May 24, 2014
COPAXONE Teva Pharms Usa glatiramer acetate 5,981,589 May 24, 2014
COPAXONE Teva Pharms Usa glatiramer acetate 6,054,430 May 24, 2014
COPAXONE Teva Pharms Usa glatiramer acetate 8,367,605 May 24, 2014
COPAXONE Teva Pharms Usa glatiramer acetate 6,620,847 May 24, 2014
COPAXONE Teva Pharms Usa glatiramer acetate 6,362,161 May 24, 2014
COPAXONE Teva Pharms Usa glatiramer acetate 7,199,098 May 24, 2014
COPAXONE Teva Pharms Usa glatiramer acetate 6,939,539 May 24, 2014
MALARONE Glaxosmithkline atovaquone; proguanil hydrochloride 6,166,046*PED May 25, 2014
MALARONE PEDIATRIC Glaxosmithkline atovaquone; proguanil hydrochloride 5,998,449*PED May 25, 2014
MALARONE PEDIATRIC Glaxosmithkline atovaquone; proguanil hydrochloride 6,291,488*PED May 25, 2014
MALARONE Glaxosmithkline atovaquone; proguanil hydrochloride 5,998,449*PED May 25, 2014
MALARONE Glaxosmithkline atovaquone; proguanil hydrochloride 6,291,488*PED May 25, 2014
MALARONE PEDIATRIC Glaxosmithkline atovaquone; proguanil hydrochloride 6,166,046*PED May 25, 2014
ALLEGRA Sanofi Aventis Us fexofenadine hydrochloride 5,578,610*PED May 26, 2014
CHILDREN'S ALLEGRA HIVES Sanofi Aventis Us fexofenadine hydrochloride 5,578,610*PED May 26, 2014
ALLEGRA HIVES Sanofi Aventis Us fexofenadine hydrochloride 5,578,610*PED May 26, 2014
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION Sanofi Aventis Us fexofenadine hydrochloride; pseudoephedrine hydrochloride 5,578,610*PED May 26, 2014
NAROPIN Fresenius Kabi Usa ropivacaine hydrochloride 5,834,489 May 26, 2014
CHILDREN'S ALLEGRA ALLERGY Sanofi Aventis Us fexofenadine hydrochloride 5,578,610*PED May 26, 2014
ALLEGRA ALLERGY Sanofi Aventis Us fexofenadine hydrochloride 5,578,610*PED May 26, 2014
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION Sanofi Aventis Us fexofenadine hydrochloride; pseudoephedrine hydrochloride 5,578,610*PED May 26, 2014
SPORANOX Janssen Pharms itraconazole 5,633,015 May 27, 2014
NEXIUM IV Astrazeneca esomeprazole sodium 6,143,771 May 27, 2014
NORDITROPIN Novo Nordisk Inc somatropin recombinant 5,633,352 May 27, 2014
RECTIV Aptalis Pharma nitroglycerin 7,189,761 May 27, 2014
CELEBREX Gd Searle celecoxib 5,563,165*PED May 30, 2014
CELEBREX Gd Searle celecoxib 5,466,823*PED May 30, 2014
ERTACZO Valeant Luxembourg sertaconazole nitrate 5,135,943 May 31, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.